[Molecular genetics of paroxysmal nocturnal hemoglobinuria].

Authors

Hiroyuki Takamori

Published in

[Rinsho ketsueki] The Japanese journal of clinical hematology. Volume 67. Issue 9. Pages 1086-1092.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disorder caused by mutations affecting the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. Recent advances in genetic analyses have shown that, in addition to PIGA mutations, rare mutations in PIGT, PIGB, and PIGV can also underlie PNH. Moreover, PNH may have an oligoclonal structure, and small PIGA-mutated clones can be detected even in healthy individuals. The expansion of PNH clones is thought to be driven not only by immune-mediated selective pressure but also, in some cases, by HMGA2 mutations and myeloid driver lesions, suggesting that PNH develops through multifactorial mechanisms that vary among patients. In addition, the genetic factors involved in progression to secondary myeloid neoplasms and response to complement inhibitors are becoming better understood. This article reviews the genetic findings relevant to PNH and discusses their clinical significance.

PMID:
42951622
Bibliographic data and abstract were imported from PubMed on 29 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.